Patent directory · USPTO A61K / A61P
Patents matching “BOEHRINGER INGELHEIM INT [DE]”
14 pharma patents match "BOEHRINGER INGELHEIM INT [DE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 14 pharmaceutical patents matching "BOEHRINGER INGELHEIM INT [DE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 20260146049
SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER
granted -
WO 2026109631
UTILISATION DE PROTÉINES ENGAGEANT LES LYMPHOCYTES T DANS LE TRAITEMENT DU CANCER
granted -
US 20260146050
KRAS DEGRADING COMPOUNDS COMPRISING SPIROCYCLIC ANNULATED 2 AMINO-3-CYANO THIOPHENES
granted -
US 20260116870
NOVEL NAV 1.1 POTENTIATORS
granted -
WO 2026082715
DÉPLÉTION DES MACROPHAGES ET VIRUS DE LA STOMATITE VÉSICULAIRE POUR LE TRAITEMENT DU CANCER
granted -
US 20260096994
SOLID DISPERSIONS HAVING STABILIZED EMULSION PARTICLES
granted -
US 20260083736
GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS FOR USE IN THE TREATMENT OF SUBSTANCE USE DISORDER IN PATIENTS WITH HIGH IMPULSIVITY
granted -
WO 2026046899
PYRAZOLO[5,1-f][1,2,4]TRIAZIN-4-ONES EN TANT QU'INHIBITEURS DE NOX4
granted -
US 20260060930
New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases
granted -
US 20260055120
Bicyclic pyrimidinones as inhibitors of NOX4
granted -
US 20260034134
TREATMENT OF CANCER WITH METASTASES IN THE CENTRAL NERVOUS SYSTEM
granted -
US 20260015393
NOVEL NMU RECEPTOR 2 AGONISTS
granted -
WO 2025257278
SÉQUENCES IMMUNOGÈNES
granted -
WO 2025252715
AGONISTE DOUBLE DU RÉCEPTEUR DU GLP-1 ET DU GLUCAGON POUR LE TRAITEMENT DE LA MASH ET DE LA CIRRHOSE
granted